|
KIAA0090 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.56650001251302E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.99090016379012E-10 |
| Normal-vs-Stage2 |
5.898100E-02 |
| Normal-vs-Stage3 |
1.804190E-02 |
| Normal-vs-Stage4 |
2.300600E-01 |
| Stage1-vs-Stage2 |
6.530400E-01 |
| Stage1-vs-Stage3 |
2.259200E-01 |
| Stage1-vs-Stage4 |
7.002000E-01 |
| Stage2-vs-Stage3 |
7.733400E-01 |
| Stage2-vs-Stage4 |
9.422600E-01 |
| Stage3-vs-Stage4 |
8.849000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.30460003805655E-09 |
| Normal-vs-AfricanAmerican |
4.19660000000599E-05 |
| Normal-vs-Asian |
4.753200E-04 |
| Caucasian-vs-AfricanAmerican |
8.460800E-01 |
| Caucasian-vs-Asian |
6.546600E-01 |
| AfricanAmerican-vs-Asian |
7.552200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.5915936063825E-12 |
| Normal-vs-Female |
2.218800E-01 |
| Male-vs-Female |
2.786500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.541700E-03 |
| Normal-vs-Extreme_Weight |
6.30917540433984E-12 |
| Normal-vs-Obese |
2.02220000000697E-06 |
| Normal-vs-Extreme_Obese |
1.174330E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.061170E-01 |
| Normal_Weight-vs-Obese |
6.755600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.412000E-01 |
| Extreme_Weight-vs-Obese |
9.174500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.394600E-01 |
| Obese-vs-Extreme_Obese |
4.743800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.188200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.05640000034069E-07 |
| Normal-vs-Age(61-80Yrs) |
2.40540032336867E-10 |
| Normal-vs-Age(81-100Yrs) |
1.02710000005057E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.055400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.603800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.976850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.658400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.070400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.965200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.3981927554928E-12 |
| Normal-VS-Type2 PRCC |
4.39399999999646E-05 |
| Normal-VS-KIRP CIMP |
2.073600E-01 |
| Normal-VS-Unclassified PRCC |
5.591300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.258000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.489900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.838100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.969800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.605200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.493700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61069999999874E-05 |
| Normal-vs-N1 |
3.399500E-02 |
| Normal-vs-N2 |
7.073600E-01 |
| N0-vs-N1 |
3.123000E-01 |
| N0-vs-N2 |
3.557200E-01 |
| N1-vs-N2 |
4.569200E-01 |
|
|
